FK949E

Phase 1Completed

1 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Healthy

Conditions

Healthy, Plasma Concentration Change of Quetiapine

Trial Timeline

Jun 1, 2009 → Aug 1, 2009

NCT ID

NCT01871987

About FK949E

FK949E is a phase 1 stage product being developed by Astellas Pharma for Healthy. The current trial status is completed. This product is registered under clinical trial identifier NCT01871987. Target conditions include Healthy, Plasma Concentration Change of Quetiapine.

What happened to similar drugs?

20 of 20 similar drugs in Healthy were approved

Approved (20) Terminated (1) Active (0)

✅mRNA-1273.712ModernaApproved

✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved

✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved

✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved

✅Perampanel 6 MGEisaiApproved

✅eszopiclone, zolpidem, placeboSumitomo PharmaApproved

✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (7)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02362412	Phase 3	Completed	Feb 18, 2015	Feb 6, 2016	Bipolar Depression
NCT01737268	Phase 3	Completed	Oct 29, 2012	Jun 29, 2016	Bipolar Disorder
NCT01919008	Phase 1	Completed	Mar 26, 2012	Jun 22, 2012	Major Depressive Disorder
NCT01924520	Phase 1	Completed	Nov 1, 2010	May 1, 2011	Major Depressive Disorder
NCT01903200	Phase 1	Completed	Feb 1, 2010	Sep 1, 2011	Major Depressive Disorder Patients
NCT01871987	Phase 1	Completed	Jun 1, 2009	Aug 1, 2009	Healthy
NCT01871974	Phase 1	Completed	May 1, 2009	Mar 1, 2010	Major Depressive Disorder Patients

Competing Products

20 competing products in Healthy

See all competitors

Product	Company	Stage	Hype Score
Use of Wearable Digital Sensors After mRNA Vaccination in Adults	Moderna	Preclinical	0
mRNA-0184	Moderna	Phase 1	0
mRNA-6231	Moderna	Phase 1	0
Letrozole	Dr. Reddy's Laboratories	Phase 1	26
Isotretinoin	Dr. Reddy's Laboratories	Phase 1	26
Fexofenadine	Dr. Reddy's Laboratories	Phase 1	26
Sertraline	Dr. Reddy's Laboratories	Phase 1	26
Nizatidine + Axid	Dr. Reddy's Laboratories	Phase 1	26
Anastrozole	Dr. Reddy's Laboratories	Phase 1	26
mRNA-1273.712	Moderna	Approved	0
Risperidone	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
Metformin + Glucophage	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
mRNA-0184	Moderna	Phase 1	0
Divalproex Sodium	Dr. Reddy's Laboratories	Phase 1	26
Sirolimus	Dr. Reddy's Laboratories	Phase 1	26
Glimepiride	Dr. Reddy's Laboratories	Phase 1	26
Ziprasidone Hydrochloride	Dr. Reddy's Laboratories	Phase 1	26
Naproxen sodium	Dr. Reddy's Laboratories	Phase 1	26